ArticleOpen forum infectious diseases2026
Maternal Colonization, Perinatal Exposure, and Neonatal Acquisition of Resistant Enterobacterales.
Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Epidemiological characteristics and pathogen profiles of non-The Pan African medical journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Enterobacterales with ampicillin (AmpR-E) and ceftriaxone resistance (CefR-E) are globally prevalent. Perinatal transmission and infections with CefR-E strains are associated with higher mortality, morbidity, and health care costs. This study estimated the rate of gut colonization of AmpR-E and CefR-E in healthy birthing parent-infant dyads in Chicago and investigated the genetic characteristics of CefR-E. Methods: Pregnant persons anticipating vaginal birth at 2 Chicago-area hospitals were enrolled. Pregnancy and birth history were obtained. Maternal vaginal and rectal swabs and infant stool samples were collected and screened for resistance. CefR-E isolates underwent whole-genome sequencing analysis. Results: Birthing parent-infant dyads were enrolled and 293 parent, and 261 infant samples were collected (July 2020-January 2023). After exclusionary criteria, parental AmpR-E colonization was 91% (216/238), and infant AmpR-E colonization was 76% (158/208). The rate of parental and infant CefR-E colonization was 12% (28/238) and 7% (15/208), respectively. Estimated perinatal transmission of CefR-E was 17% (4/24). Race was the only clinical variable significantly associated with parental CefR-E colonization (higher Asian, decreased White race). Birthing parent age and type of infant nutrition (breastmilk) were significantly associated with decreased infant AmpR-E colonization ( Conclusions: This study demonstrates that a sizable percentage of healthy pregnant persons are colonized with AmpR-E and CefR-E in the United States, a higher burden than previously reported for high-income countries. Enterobacterales appear adept in perinatal transmission, with a significant proportion of infants born to colonized pregnant persons harboring CefR-E in the first week of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.